Marksans Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Profit before tax

171.89

132.04

134.51

124.33

52.73

Net cashflow-operating activity

34.05

51.73

50.97

107.07

118.01

Net cash used in investing activity

-114.22

-194.62

-8.40

8.82

-24.10

Netcash used in fin. activity

-26.22

210.02

75.86

-13.53

-92.29

Net inc/dec in cash and equivlnt

-106.38

67.12

118.44

102.36

1.63

Cash and equivalnt begin of year

148.31

81.19

105.61

3.35

1.12

Cash and equivalnt end of year

41.93

148.31

224.05

105.71

2.75